Vertex Pharmaceuticals Incorporated NMS · VRTX
Price alert —
Sign in to get a one-time email the moment VRTX crosses your price. Free accounts included.
Sign in / create a free accountVertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally.
VRTX last traded at $481.80, up 0.3% on the day; that's in the middle part of its 52-week range ($412.27–$533.67). Right now it's trading close to its recent average, with no strong stretch in either direction.
The next scheduled earnings report (2026-08-03) is the biggest known catalyst on the calendar, and day to day, watch whether it holds above or slips below its recent average.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
above KC1 lower, -0.13 ATR from EMA21 — no notable pattern
- · Aligned with strong uptrend (strong tailwind)
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
- · Stochastic bear cross
- · Counter-trend short in strong uptrend
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
VRTX is a $122.3 billion company, priced at 29× last year's earnings, and it moves more calmly than the market (beta 0.3).
Options idea
See more →Earnings
See more →- Last reported
- 2026-05-04
- EPS (act / est)
- 4.47 / 4.31
- Surprise
- +3.8%
- Next report
- 2026-08-03
About
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRI…